Wednesday, March 10, 2010
"The source for European pharmaceutical biotechnology news..."
Why the rise of generics could mean a new game plan for the industry; plus Nycomed's leap into the big time.
Sponsors
Platinum Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.05 Aug 2009
Upcoming Issue
Coverage Areas
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.